Exchange: OTC·Updated 02:22 PM EST

OZYMF Orphazyme A/S

$90.00
$90.00
(0.00%)
Today
Mkt Cap$4,900.00

About OZYMF

Strategic Partners A/S is a biopharmaceutical company, which engages in the research and development of treatments for rare diseases. It provides Arimoclomol program and molecular entities program. The company was founded by Anders Morkeberg Hinsby, Marja Jaattela, Martin Rahbek Kornum, and Thomas Kirkegaard Jensen in 2009 and is headquartered in Copenhagen, Denmark.
50

Neutral Sentiment

How do you feel about OZYMF?

Advertisement|Remove ads.